| Heading: |
Parkinson's Disease: Medical Treatments |
| Question ID: |
1790151 |
| UIN: |
42322 |
| House: |
Commons |
| Date tabled: |
2025-03-28 |
| Asking Member ID: |
4610 |
| Asking Member display name: |
Bambos Charalambous
|
| Asking Member handle: |
BambosMP
|
| Asking Member Twitter reference: |
@BambosMP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce variations in access to treatments approved by the National Institute for Health and Care Excellence for advanced and complex Parkinson’s Disease. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
We have delivered an additional two million appointments in England, seven months ahead of schedule. This includes operations, consultations, diagnostic tests, and treatments. These additional appointments have taken place across a number of specialities,... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |